Day 1 of One Month to a Better Board

Day 1 of One Month to a Better Board

Case Law As to the specific role of ‘Best Practices’ in the area of general compliance and ethics, one can look to Delaware corporate law for guidance. The case of In Re Caremark International Inc. was the first case to hold that a Board’s obligation “includes a duty to attempt in good faith to assure that a corporate information and reporting system, which the board concludes is adequate, exists, and that failure to do so under some circumstances may, in theory at least, render a director liable for losses caused by non-compliance with applicable legal standards.” In the case of Stone v. Ritter, the Supreme Court of Delaware expanded on the Caremark decision by establishing two important principles. First, the Court held that the Caremark standard is the appropriate standard for director duties with respect to corporate compliance issues. Second, the Court found that there is no duty of good faith that forms a basis, independent of the duties of care and loyalty, for director liability. Rather, Stone v. Ritter holds that the question of director liability turns on whether there is a "sustained or systematic failure of the board to exercise oversight – such as an utter failure to attempt to assure a reasonable information and reporting system exists.” According to Haynes and Boone in its publication, “Corporate Governance and the Role of the Board” a director’s business decisions generally qualify for protection by the “business judgment rule.” Under the business judgment rule, courts presume that directors making business decisions acted on an informed basis, in good faith, and with the honest belief that the action taken was in the best interests of the corporation. In lawsuits brought against directors brought by shareholders, courts applying the business judgment rule will determine only whether the directors making the decision (i) were free from conflicts of interest, (ii) appropriately informed themselves before taking the action, and (iii) acted after due consideration of all relevant information that was reasonably available. Under the business judgment rule, the board’s action will not subject board members to liability if the action or decision of the directors can be attributed to any rational business purpose. Directors that meet the criteria of the business judgment rule do not have to worry about having their business decisions second-guessed by a court, even where their decisions result in corporate losses. FCPA Guidance and US Sentencing Guidelines A Board’s duty under the Foreign Corrupt Practices Act (FCPA) is well known. In the Department of Justice (DOJ)/Securities and Exchange Commission (SEC) FCPA Guidance, under the Ten Hallmarks of an Effective Compliance Program, there are two specific references to the obligations of a Board. The first in Hallmark No. 1, entitled “Commitment from Senior Management and a Clearly Articulated Policy Against Corruption”, states “Within a business organization, compliance begins with the board of directors and senior executives setting the proper tone for the rest of the company.” The second is found under Hallmark No. 3 entitled “Oversight, Autonomy and Resources”, where it discusses that the Chief Compliance Officer (CCO) should have “direct access to an organization’s governing authority, such as the board of directors and committees of the board of directors (e.g., the audit committee).” Further, under the US Sentencing Guidelines, the Board must exercise reasonable oversight on the effectiveness of a company’s compliance program. The DOJ’s Prosecution Standards posed the following queries: (1) Do the Directors exercise independent review of a company’s compliance program? and (2) Are Directors provided information sufficient to enable the exercise of independent judgment? There is one other issue regarding the Board and risk management, including FCPA risk management, which should be noted. It appears that the SEC desires Boards to take a more active role in overseeing the management of risk within a company. The SEC has promulgated Regulation SK 407 under which each company must make a disclosure regarding the Board’s role in risk oversight which “may enable investors to better evaluate whether the board is exercising appropriate oversight of risk.” If this disclosure is not made, it could be a securities law violation and subject the company, which fails to make it, to fines, penalties or profit disgorgement. From the Delaware cases, I believe that a Board must not only have a corporate compliance program in place but actively oversee that function. Further, if a company’s business plan includes a high-risk proposition, there should be additional oversight. In other words, there is an affirmative duty to ask the tough questions. The specific obligations set out regarding the FCPA drive home these general legal obligations down to the specific level of the statute. Three Key Takeaways The Delaware courts have led the way with the Caremark and Stone v. Ritter decisions. Note the obligations of the Board under the 10 Hallmarks of an Effective Compliance Program. The US Sentencing Guidelines also require Board involvement and oversight. For more information, check out my book Doing Compliance: Design, Create and Implement an Effective Anti-Corruption Compliance Program, which is available by clicking here. Learn more about your ad choices. Visit megaphone.fm/adchoices

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(1613)

AI in Compliance and Eastward AI’s Continuous Risk “Reality Check”

AI in Compliance and Eastward AI’s Continuous Risk “Reality Check”

Welcome to the award-winning FCPA Compliance Report, the longest-running podcast in compliance. In this episode, Tom welcomes back Gerry Zack, and they discuss the growing use of AI in compliance and ...

13 Juli 29min

Managing Compliance and National Security Risks When Doing Business in the DRC, Part 2

Managing Compliance and National Security Risks When Doing Business in the DRC, Part 2

In this episode, Tom Fox welcomes David Simon, Partner at Foley & Lardner; Jack Korba, Of Counsel at Foley & Lardner; and Olivier Bustin, a Partner at Pinsent Masons, to discuss doing business in and ...

29 Juni 24min

Managing Compliance and National Security Risks When Doing Business in the DRC, Part 1

Managing Compliance and National Security Risks When Doing Business in the DRC, Part 1

In this episode, Tom Fox welcomes David Simon, Partner at Foley & Lardner; Jack Korba, Of Counsel at Foley & Lardner; and Olivier Bustin, a Partner at Pinsent Masons, to talk about doing business in a...

22 Juni 29min

Data Defensibility: The Foundation of AI Readiness with George Tziahanas

Data Defensibility: The Foundation of AI Readiness with George Tziahanas

In this episode, Tom Fox welcomes George Tziahanas, VP of Compliance and Associate General Counsel at Archive360, who brings a practical legal and governance perspective to the challenges of AI and da...

15 Juni 30min

Leading with Invitation: Communications, Leadership, and Compliance with Dr. Dennis Cummins

Leading with Invitation: Communications, Leadership, and Compliance with Dr. Dennis Cummins

In this episode, Tom Fox welcomes Dr. Dennis Cummins to discuss his latest book, Invitational Selling: The Human Connection Advantage. Dr. Cummins is a renowned expert in the field of invitational sel...

8 Juni 31min

Matt Ellis on Cartels, FTO Risk, and Corporate Compliance in Latin America

Matt Ellis on Cartels, FTO Risk, and Corporate Compliance in Latin America

In this episode, Tom Fox welcomes Matt Ellis of Miller & Chevalier about the ACI “Cartels, TCOs and Compliance in Latin America” forum (July 20–21, Washington, DC) and why cartel/TCO/FTO risk is a tim...

1 Juni 25min

Report from Compliance Week 2026 on AI Sessions

Report from Compliance Week 2026 on AI Sessions

In this episode, Tom Fox takes a solo turn behind the mic to report on the AI tracks from the recently concluded Compliance Week 2026 conference. He highlights two AI tracks: practical “creative” use...

11 Maj 21min

Building a Life Sciences Compliance Law Firm with Edye Edens

Building a Life Sciences Compliance Law Firm with Edye Edens

In this episode, Tom Fox welcomes Edye Edens about launching her Life Sciences Law Group (“Eedee Law”) after years of contracting in life sciences compliance across multiple firms. Edye explains she ...

4 Maj 34min

Populärt inom Business & ekonomi

badfluence
framgangspodden
dynastin
varvet
rss-borsens-finest
uppgang-och-fall
svd-tech-brief
rss-inga-dumma-fragor-om-pengar
bathina-en-podcast
avanzapodden
fill-or-kill
rss-dagen-med-di
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-kort-lang-analyspodden-fran-di
tabberaset
market-makers
rss-borslunch
borslunch-2
rss-dominoeffekten
rss-veckans-trade